What is the Y-tunnus number of GlaxoSmithKline Oy?

GlaxoSmithKline Oy is registered with PRH / YTJ under Y-tunnus 0108378-4.

What is the revenue of GlaxoSmithKline Oy?

GlaxoSmithKline Oy reported revenue of EUR 77,6M in 2025.

GlaxoSmithKline Oy employs 86 people as of the latest annual report.

Robert Håkan Kajander is Audit of GlaxoSmithKline Oy, in role since 2021.

Anne Margaret Belcher chairs the board of GlaxoSmithKline Oy, in role since 2020.

GlaxoSmithKline Oy's registered address is Porkkalankatu 20-A.

OYActive

Y-tunnus 0108378-4Porkkalankatu 20A, 00180 HelsinkiWholesale of pharmaceutical and medical goods · NACE 4646Est. 197086 employees

Actively employed in the business

Name	Role	Member since
Current (2)
SG Sally Georgina Pearman Chief Executive Officer	Chief Executive Officer	2024
TH Terhi Hannele Hirvonen Person with significant control	Person with significant control	2022
Former (6)
RH Robert Håkan Kajander Audit	Audit	2021 – 2023
MK Merja Kristiina Itäniemi Audit	Audit	2018 – 2021
SD Sarah Danielle Kleinpeter Chief Executive Officer	Chief Executive Officer	2020 – 2021
TM Tanja Maaret Veikkola Chief Executive Officer	Chief Executive Officer	2021 – 2024
SD Sarah Danielle Kleinpeter Chief Executive Officer	Chief Executive Officer	2020 – 2020
SS Sabena Solomon Chief Executive Officer	Chief Executive Officer	2017 – 2020

Non-executive oversight

Name	Role	Member since
Current (3)
SK Satu Katri Annukka Sumanen	Board of Directors	2023
JJ Juhana Juhananpoika Idänpään-Heikkilä	Board of Directors	2023
PM Peter Magnus Wangel	Board of Directors	2025
Former (8)
SN Saif Nouira	Board of Directors	2021 – 2025
VL Vytautas Liatukas	Board of Directors	2021 – 2021
AM Anne Margaret Belcher	Chairperson	2020 – 2022
PG Patrick Gerard Connor	Chairperson	2022 – 2023
JM James Macadam	Board of Directors	2018 – 2019
TL Tetiana Luczkiw	Board of Directors	2021 – 2023
NA Neale Andrew Belson	Chairperson	2018 – 2020
MJ Mark J Waxman	Board of Directors	2019 – 2021

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.